Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Liabilities from Discontinued Operations (2024)

Historic Liabilities from Discontinued Operations for Aytu Biopharma (AYTU) over the last 1 years, with Q2 2024 value amounting to $557000.0.

  • Aytu Biopharma's Liabilities from Discontinued Operations changed N/A to $557000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $557000.0, marking a year-over-year change of. This contributed to the annual value of $557000.0 for FY2024, which is N/A changed from last year.
  • As of Q2 2024, Aytu Biopharma's Liabilities from Discontinued Operations stood at $557000.0.
  • Over the past 5 years, Aytu Biopharma's Liabilities from Discontinued Operations peaked at $557000.0 during Q2 2024, and registered a low of $557000.0 during Q2 2024.